David Charles Lubner, SVP and CFO at TETRAPHASE PHARMACEUTICALS INC (TTPH), sold 13,530 shares at $12.51 ($169K) on 2014-06-17, disclosed to the SEC on 2014-06-18.
Scheduled sale ($169k) by SVP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PNT | BUY | 2022-11-28 | $25K | — | Filing → |
| TTPH | SELL | 2015-08-17 | $408K | — | Filing → |
| TTPH | SELL | 2015-07-15 | $367K | — | Filing → |